We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
&SISTERS is a femcare company offering products that are hypoallergenic, pH-neutral and free from chlorine, pesticides & perfumes. It has sold 225,000+ certified organic cotton period products, directly to 300+ customers. The company has many listed retailers including Feel Unique, Farmdrop and Triyoga and exports to many countries including Asia and Europe. In January 2020, &SISTERS is planning to launch a new paper-wrapped naked tampon®. With the proceeds, the company will expand the product range, expand the team, raise awareness and accelerate sales.
days to go: Expired investment: £199,630
Kiddyum have won multiple awards for their nutritious and delicious frozen meals for young children. They are currently stocked in over 320 sainsbury's nationwide and on Ocado.com. All ready meals are made from natural ingredients with no added sugar, preservatives, GM ingredients or artificial colours or flavours.
days to go: Expired investment: £61,310
Miso Tasty is a Japanese inspired food brand that specialises in the production and sale of Miso, a delicacy of Japan. To maintain authenticity, the company sources its key ingredients directly from Japan and has experience of over six years in manufacturing a range of delicacies such as Miso Soups, Miso Pastes, and Meal Kits. Led by an award-winning entrepreneur, author, and creative chef Bonnie Chung, Miso Tasty has established itself into the UK's top two supermarkets -Tesco and Sainsbury's. It's products have been featured in publications such as The Guardian, Daily Mail, and The Sunday Telegraph. Celebrity Chef Jamie Oliver mentioned Miso Tasty on his TV show. The brand has also launched a collaboration menu with Masterchef Winner Tim Anderson's restaurant, NanBan. With the funds received, Miso Tasty will put more efforts into brand awareness within the UK, launch product ranges such as marinades and sauces that delve deeper into Japanese cuisine, recruit more staff and capital resources to further the brand's business.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £384,088
Raw Press is London's first cold-pressed juice cafe, a premium highstreet concept for the health concious consumer. They currently have 2 locations, both being in London; with one in Mayfair and one in Chelsea. Raw Press also sell direct to consumers through their website and delivery partners. 
days to go: Expired investment: £50,460
iChef use an online platform to connect the best catering companies to professional establishments and consumers. iChef is lead by a panel of world famous chefs, amongst the names are Mark Hix and Giorgio Locatelli. 
days to go: Expired investment: £5,974
Cellar Rats, led by Founder and CEO Matt, aims to disrupt the wine industry by changing the way people discover, buy, and enjoy wine. With a background in successfully transforming consumer brands, they're determined to revolutionize the UK's £17 billion wine market, which currently faces challenges due to a lack of consumer wine knowledge. Starting with a subscription service and extending to shake up traditional wine retail, Cellar Rats is poised to reshape the wine industry from the ground up.
days to go: Expired investment: £282,164
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph